Leaders in Healthcare

In the past decade, AMV has assembled
the leading early-stage digital health portfolio

What We Look For

Digital Health is growing at a rapid rate

Since 1965, we have worked with entrepreneurs in life sciences and technology.

We have extensive operating experience as founders of companies. We have an unparalleled network of digital health stakeholders to aid entrepreneurs. We have insight into emerging trends in digital health to discover and evaluate opportunities. Leveraging these assets, we can help you build transformative companies to change the world.

Working with early-stage startups in digital health, technology, and life sciences, we take an active role to assist founders in tackling typical early-stage challenges around hiring, strategic focus, technical development, sales channels, and business partnerships. We partner with other top-tier venture firms when our companies raise later-stage capital. We look for teams with integrity, transparency, and deep market and technical knowledge. Our founders think differently and are unafraid to dream.

EARLY STAGE

Seed and Series A

DEFENSIBILITY

Unique Technology
Data-Driven

MARKET

Ripe for Disruption
Massive Opportunity

TEAM

True Domain Experts
Passionate and Committed

The Healthcare Industry

Healthcare is a $7T annual market with $3.2T spent in the United States

Healthcare is a complex and fascinating industry that continues to evolve and grow. US healthcare has grown to $3.2 trillion annually and accounted for 17.8% of GDP. This is expected to rise to 20.1% of GDP by 2025.

At AMV, we believe there is a significant market opportunity to reduce healthcare costs and improve access to care by applying emerging digital technologies to healthcare. The Affordable Care and HITECH acts catalyzed the adoption of electronic medical records and helped start to shift U.S. healthcare payments from a fee-for-service model to one that is outcome based. Still, the overall market lacks transparency and will benefit from improved efficiencies and scalability provided by modern technologies.

New data streams enabled by smartphones and low-cost genomic sequencing have paved the way for novel approaches in precisely understanding, detecting, and treating both chronic and complex diseases, which will lead to better and more economic outcomes. We are excited about the future of digital health and how advanced technologies can be utilized to help our growing population lead longer and healthier lives.

AMV

AMV is a venture capital firm investing in
early-stage digital health, technology and
life sciences companies.

2100 Geng Road, Suite 200
Palo Alto, CA
650.621.8808

© 2017 Asset Management Ventures
All Rights Reserved